References

  1. Shaw TA, Stiffel L, Chronic hepatitis. In; Mandell GL Bennett JE, Dolin R, eds. Principles and Practice of infectious Disease. 5th ed.

  2. Cooper CL, Mills E, WabwireBO, Ford N, Olupot-Olupot P. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in Sub-Saharan Africa. Int J Infect Dis. 2009 May; 13(3):302-6. This article on PubMed

  3. Ola SO, OtegbayoGN, Odaibo OD, Olaleye OD, Olubuyide O. Serum Hepatitis C virus and hepatitis B surface antigenaemia in Nigerian patients with acute Icteric hepatitis. West Afr J Med. 2002 Jul-Sep; 21(3):215-7. This article on PubMed

  4. Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM. The role of triple infection with hepatitis Bvirus, hepatitis C virus, and human immunodeficiency virus(HIV) type -1 on CD4+ lymphocyte levels in the highly HIV infected population of North Central Nigeria. Mem Inst Oswaldo Cruz. 2007 Jun; 102(4):535-7. This article on PubMed

  5. Bojuwoye BJ. The burden of viral hepatitis in Africa. West Afr J Med. 1997 Oct-Dec; 16(4):198-203. This article on PubMed

  6. ThioCL, Sea berg EC, Skolasky R Jr et al. HIV-1 hepatitis B virus and risk of liver related mortality in Multicentre Cohort Study (MACS). Lancet. 2002; 360:1921-1926. This article on PubMed

  7. Centers for Disease Control and Prevention (CDC). Recommendations for the Prevention and Control of Hepatitis C virus (HCV) infection and HCV related chronic disease. MMWR Recomm Rep. 1998 Oct 16; 47(RR-19):1-39. This article on PubMed

  8. Parboosing R, Paruk I, Lalloo UG. Hepatitis C virus seropositivity in a South African cohort of HIVinfected, ARV naive patients is associated with renal insufficiency and increased mortality. J Med Virol. 2008 Sep; 80(9):1530-6. This article on PubMed

  9. Dodig M. Hepatitis C and human immunodeficiency virus confections. J Clin Gastroenterol. 2001 Nov-Dec; 33(5):367-74. This article on PubMed

  10. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology. 2002 Nov; 36(5 Suppl 1):S201-9. This article on PubMed

  11. Greub G. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C co infection, Swiss HIV cohort study. Lancet. 2000; 356:1800-1805. This article on PubMed

  12. Diop-Ndiaye H, Toure-Kane C, Etard JF, Lo G, Diaw P, Ngom-Gueye NF, Gueye NF et al. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation. J Med Virol. 2008 Aug; 80(8):1332-6. This article on PubMed

  13. Larsen C, Pialoux G, Salmon D, Antona D, Le Strat Y, Piroth L et al. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France. Euro Surveill. 2008; 13 (22):18888. This article on PubMed

  14. Akanmu AS, Esan OA, Adewuyi JO, DaviesAO, OkanyC C, Olatunji RO, Babalola T. Evaluation of a rapid test kit for detection of HBsAg/eAg in whole blood: a possible method for pre-donation testing. Afr J Med med Sci. 2006; 35: 5-8. This article on PubMed

  15. Durosinmi MA, Ndububa DA, Alabi OA, et al. Prevalence of HIV-1 and HBsAg in normal blood donors in Ile-lfe, Nigeria. Nig Med J. 1992; 21(13):138-140

  16. irisena ND, Njoku MD, Idoko JA. Hepatitis surface antigenaemia in patients with human immunodeficiency virus -1(HIV-1) infection in Jos, Nigeria. Nig Med Pract. 2002; 41(12):18-20.

  17. Olatunji OP, Iseniyi JO. Hepatitis B and C viruses’ co-infection with human immunodeficiency virus infected patients at UITH, IIorin. Nig Med Pract. 2008; 54(1):8-10.

  18. Nwokedi EE, Epopees MA, Dutse AI. Human immunodeficiency virus and hepatitis B virus co infection among patients in Kano, Nigeria. Niger J Med. 2006 Jul-Sep; 15(3):227-9. This article on PubMed

  19. Stud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawia Y. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001; 22(2):90-92. This article on PubMed

  20. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath, Johannesburg. East African Medical Journal. 2000; 77(1): 13-15. This article on PubMed

  21. Baba MM, Gushau W, Hassan A W. Detection of hepatitis-B surface antigenaemia in patients with and without the manifestations of AIDS in Maiduguri, Nigeria. Postgrad Med J. 1998; 5 (3): 125-127.

  22. Lesi O A, Kehinde M O, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J. 2007 Jun; 14(2):129-33. This article on PubMed

  23. Ejele OA, Nwauche C A, Erhabor O. The Prevalence of Hepatitis B surface Antigenaemia in HIV positive patients in the Niger Delta Nigeria. Niger J Med. 2004 Apr-Jun; 13(2):175-9. This article on PubMed

  24. Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A. Prevalence of hepatitis B virus and hepatitis C co infection with human immunodeficiency virus in Thai patients: a tertiary case based study. J Med Assoc Thai. 2004; 87 (11):1349-1354. This article on PubMed

  25. Agwale SM, TanimotoL, Womack C, Odama L, Leung K, DueyD et al. Prevalence of HCVcoinfection in HIV-infected individuals in Nigeria and characterization of HCV genotype. J Clin Virol. 2004 Dec; 31 Suppl 1:S3-6. This article on PubMed

  26. Wright TL, Honnander H, Pu X, Held M J, Lipson P, Quan S, et al. Hepatitis C in HIV infected patients with and without AIDS, prevalence and relationship to survival. Hepatology. 1994; 20:1152. This article on PubMed

  27. Otegbayo JA, Taiwo BO, AkingbolaTS, OdaiboGN, Adedapo KS, Penugonda S et al. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol. 2008; 7(2):152-6. This article on PubMed

  28. Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B, and hepatitis C co infection in Kenya. AIDS. 2008; 22(10):1221-1222. This article on PubMed